Search Tag: Priftin

Pharmacy Management

Fda-approves-priftin-r-for-ltbi

2014 05 Dec

FDA has approved Priftin® (rifapentine) for the treatment of latent tuberculosis infection (LTBI). Priftin®, an antimycobacterial used for the treatment of active pulmonary TB has now been approved for LTBI, a new indication, to be used in combination with isoniazid (INH) in patients two years of age and older and at high risk of progression...Read more